Cancer Research and Treatment

Assessment and prognostic significance of a serum cytokine panel in diffuse large B‑cell lymphoma

Shufang Xie, Lifen Zhu, Lei Wang, Shibing Wang, Xiangmin Tong, Wanmao Ni

Cancer and thrombosis—platelets and anti-platelet drugs—

Japanese Journal of Thrombosis and Hemostasis.2023; 34(5): 549. CrossRef

Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma

Nonthakorn Hantrakun, Phichayut Phinyo, Adisak Tantiworawit, Ekarat Rattarittamrong, Chatree Chai-Adisaksopha, Thanawat Rattanathammethee, Sasinee Hantrakool, Pokpong Piriyakhuntorn, Teerachat Punnachet, Piangrawee Niprapan, Lalita Norasetthada

Journal of Thrombosis and Thrombolysis.2023; 57(3): 473. CrossRef

Incidence and Risk Factors of Venous Thromboembolism Following Hepatectomy for Colorectal Metastases: A Population‐Based Retrospective Cohort Study

Nader Hanna, Susan B. Brogly, Xuejiao Shelly Wei, Christopher M. Booth, Sulaiman Nanji

Venous‐thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma

Radhika Gangaraju, Elizabeth S. Davis, Smita Bhatia, Kelly M. Kenzik

Issue of predicting the risk of thromboembolic complications in patients with lymphoproliferative diseases

S. V. Ignatiev, A. V. Lyanguzov, E. S. Fokina, N. A. Zorina, K. A. Vorobiev

Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study

Maja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, Henriette Engberg, Pernille Hammershøj Jensen, Helene Bjørg Kristensen, Joachim Baech, Michael Roost Clausen, Anne Ortved Gang, Lars Munksgaard, Tarec Christoffer El-Galaly, Henrik Frederiksen, Thomas

Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature

Manlio Monti, Pietro Cortesi, Roberto Vespignani, Ilaria Bronico, Chiara Gallio, Michele Flospergher, Laura Matteucci, Giovanni Luca Frassineti

Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis

Silvia García Adrián, Adán Rodríguez González, Eva Martínez de Castro, Vanessa Pachón Olmos, Laura Ortega Morán, Purificación Martínez del Prado, Mercedes Salgado Fernández, José David Cumplido Burón, Ignacio García Escobar, Joaquina Martínez Galán, Ana I

European Journal of Internal Medicine.2022; 105: 30. CrossRef

Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features

Yingxia Lan, Jinqiu Guan, Jia Zhu, Juan Wang, Mengzhen Li, Chengtao Sun, Feifei Sun, Junting Huang, Suying Lu, Yizhuo Zhang

Predicting the Incidence of Venous Thromboembolism Using the Khorana Score: A Literature Review

The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma

Hikmat Abdel-Razeq, Mohammad Ma’koseh, Asem Mansour, Rayan Bater, Rula Amarin, Alaa Abufara, Khalid Halahleh, Mohammad Manassra, Mohammad Alrwashdeh, Mohammad Almomani, Mais Zmaily

Clinical and Applied Thrombosis/Hemostasis.2021; 27: 107602962110459. CrossRef

Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH

J. R. Gonzalez-Porras, J. Mateo, V. Gonzalez-Calle, P. Marco, V. Garcia-Gutierrez, J. C. Reverter, R. Lecumberri

Clinical and Translational Oncology.2021; 24(5): 770. CrossRef

The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma

Onur Kirkizlar, Tugcan Alp Kirkizlar, Elif Gulsum Umit, Ismail Asker, Mehmet Baysal, Volkan Bas, Sedanur Karaman Gulsaran, Ufuk Demirci, Ahmet Muzaffer Demir

Clinical Lymphoma Myeloma and Leukemia.2020; 20(8): 542. CrossRef

Prediction of survival in non-Hodgkin lymphoma based on markers of systemic inflammation, anemia, hypercoagulability, dyslipidemia, and Eastern Cooperative Oncology Group performance status

Ivan Dzis, Oleksandra Tomashevska, Yevhen Dzis, Zoryana Korytko

Acta Haematologica Polonica.2020; 51(1): 34. CrossRef

Mechanisms and biomarkers of cancer-associated thrombosis

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis

Stefan Hohaus, Francesca Bartolomei, Annarosa Cuccaro, Elena Maiolo, Eleonora Alma, Francesco D’Alò, Silvia Bellesi, Elena Rossi, Valerio De Stefano

Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis

Knut A. Mosevoll, Silje Johansen, Øystein Wendelbo, Ina Nepstad, Øystein Bruserud, Håkon Reikvam

Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice

Joanna Rupa‐Matysek, Katarzyna Brzeźniakiewicz‐Janus, Lidia Gil, Zbigniew Krasiński, Mieczysław Komarnicki

Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma

Joanna Rupa-Matysek, Lidia Gil, Marta Barańska, Dominik Dytfeld, Mieczysław Komarnicki

Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B‐cell lymphoma

Joanna Rupa‐Matysek, Lidia Gil, Renata Kroll‐Balcerzak, Marta Barańska, Mieczysław Komarnicki

Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients

Patrizia Ferroni, Fabio Massimo Zanzotto, Noemi Scarpato, Silvia Riondino, Umberto Nanni, Mario Roselli, Fiorella Guadagni

Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma

Ina Hornemann Borg, Mette Dahl Bendtsen, Martin Bøgsted, Jakob Madsen, Marianne Tang Severinsen

Risk of thromboembolism with lymphoma: myth or reality?

Kate L. Burbury, Marliese Alexander, David A. Westerman